The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity
- PMID: 11323286
- DOI: 10.1016/s1471-4906(01)01896-8
The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity
Abstract
The identification of tumor antigens has generated a resurgence of interest in immunotherapy for cancer. However, both clinical and animal studies suggest that therapeutic strategies that have mainly focused on the use of CD8+ T cells (and MHC class I-restricted tumor antigens) are not effective in eliminating cancer cells. Recent interest has been directed towards the use of CD4+ T cells in generating antitumor immunity. To this end, the identification of MHC class II-restricted tumor antigens that can stimulate CD4+ T cells might provide opportunities for developing effective cancer vaccines.
Comment in
-
MHC class II-restricted tumor antigens and CD4+ T cells play a role in hematological malignancies as well as solid tumors.Trends Immunol. 2001 Aug;22(8):422-3. doi: 10.1016/s1471-4906(01)01987-1. Trends Immunol. 2001. PMID: 11491092 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
